Yalan Wang
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Oncology top 10%
- PARP inhibition in cancer therapy
Papers in
-
- Epigenetics and DNA Methylation 7
- RNA modifications and cancer 6
- Cell death mechanisms and regulation 5
- Ubiquitin and proteasome pathways 4
- Oncology 32
- PARP inhibition in cancer therapy 26
- Co-authors
- Yi Tang (20 shared papers)Ming Xiao (19 shared papers)Zhong‐Jian Yang (1 shared paper)Xiao‐Niu Peng (1 shared paper)Shan Liang (1 shared paper)Fei‐Fei Jin (1 shared paper)Andrew G. Turner (1 shared paper)Min Li (1 shared paper)
- Journals
- International Journal of Molecular Medicine (4 papers)Scientific Reports (3 papers)Oncology Reports (3 papers)Pathology & Oncology Research (3 papers)Protein & Cell (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Yalan Wang
95 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 134
- Hepatology 239
- Oncology 232
- Physiology 40
- Renewable Energy, Sustainability and the Environment 132
- Oceanography 83
Countries citing papers authored by Yalan Wang
This map shows the geographic impact of Yalan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yalan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yalan Wang more than expected).
Fields of papers citing papers by Yalan Wang
This network shows the impact of papers produced by Yalan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yalan Wang. The network helps show where Yalan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yalan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 252 | |
| 2 | 2011 | 171 | |
| 3 | 2015 | 120 | |
| 4 | 2019 | 96 | |
| 5 | 2019 | 58 | |
| 6 | 2010 | 38 | |
| 7 | 2023 | 31 | |
| 8 | 2020 | 29 | |
| 9 | 2023 | 26 | |
| 10 | 2019 | 26 | |
| 11 | 2013 | 26 | |
| 12 | 2019 | 25 | |
| 13 | 2021 | 23 | |
| 14 | 2016 | 23 | |
| 15 | 2016 | 23 | |
| 16 | 2013 | 23 | |
| 17 | 2022 | 22 | |
| 18 | 2009 | 22 | |
| 19 | 2019 | 22 | |
| 20 | 2016 | 20 |
About Yalan Wang
Yalan Wang is a scholar working on Molecular Biology, Oncology, Epidemiology, Immunology and Pulmonary and Respiratory Medicine, having authored 111 papers that have together received 1.6k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (26 papers), Toxin Mechanisms and Immunotoxins (10 papers), Epigenetics and DNA Methylation (7 papers), RNA modifications and cancer (6 papers), Ophthalmology and Visual Impairment Studies (6 papers), Ferroptosis and cancer prognosis (6 papers), Cell death mechanisms and regulation (5 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Hepatology (239 citations), Oncology (232 citations), Physiology (40 citations), Renewable Energy, Sustainability and the Environment (132 citations) and Oceanography (83 citations). Yalan Wang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Yi Tang, Ming Xiao, Zhong‐Jian Yang, Xiao‐Niu Peng, Shan Liang, Fei‐Fei Jin, Andrew G. Turner, Min Li, Xue‐Feng Yu and Wenjun Zhang. Their work appears in journals such as International Journal of Molecular Medicine, Scientific Reports, Oncology Reports, Pathology & Oncology Research and Protein & Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.